Keyvan Rahmani

Dr. Keyvan Rahmani


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2006 in Computer-Aided Design
Verified
Journal Article
Closed access
KRKeyvan Rahmani
Keyvan Rahmani
BABehrooz Arezoo
Behrooz Arezoo

10 June 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
MFMaxime Faucher
Maxime Faucher
DCDavid Satish Casie Chetty
David Satish Casie Chetty
SSSepideh Shokouhi
Sepideh Shokouhi
GBGina Barnes
Gina Barnes
KRKeyvan Rahmani
Keyvan Rahmani
QMQingqing Mao
Qingqing Mao
(1) Background: Ventilator-associated pneumonia (VAP) causes high mortality among patients with respiratory disease and imposes major burdens on healthcare infrastructure. Models that use electronic health record data to predict the onset of VAP may spur earlier treatment and improve patient outcomes. We developed and studied the performance of interpretable machine learning (ML) models that predict the onset of VAP from electronic health records (EHRs); (2) Methods: We trained Logistic Regression (LR), full feature Explainable Boosting Machine (fEBM), and eXtreme Gradient Boosting (XGBoost) ML models on data from the MIMIC- III (v1.3) database. Model performance was measured by area under the receiver operating characteristic curves (AUCs). We trained a minimal-feature EBM model (mEBM) with features derived from white blood cell (WBC) counts, duration of ventilation, and Glasgow Coma Scale (GCS). Finally, model robustness was evaluated on randomly sparsified EHR datasets; (3) Results: The fEBM model outperformed the XGBoost and LR models at 24 hours post-intubation. The mEBM model maintained an AUC of 0.893. The fEBM model performance remained robust on sparsified datasets; (4) Conclusions: Our novel interpretable ML algorithm reliably predicts the onset of VAP in intubated patients. Integration of this EBM-based model into clinical practice may enable clinicians to better anticipate and prevent VAP.